| Year |
Citation |
Score |
| 2023 |
Yao M, Preall J, Yeh J, Pappin DJ, Cifani P, Zhao Y, Shen S, Moresco P, He B, Patel H, Habowski AN, King DA, Raphael KL, Rishi A, Sejpal DV, et al. Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies to self-antigens. Jci Insight. PMID 37751306 DOI: 10.1172/jci.insight.172449 |
0.434 |
|
| 2022 |
Demyan L, Habowski AN, Plenker D, King DA, Standring OJ, Tsang C, St Surin L, Rishi A, Crawford JM, Boyd J, Pasha SA, Patel H, Galluzzo Z, Metz C, Gregersen PK, et al. Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy. Annals of Surgery. 276: 450-462. PMID 35972511 DOI: 10.1097/SLA.0000000000005558 |
0.443 |
|
| 2022 |
Chun SK, Fortin BM, Fellows RC, Habowski AN, Verlande A, Song WA, Mahieu AL, Lefebvre AEYT, Sterrenberg JN, Velez LM, Digman MA, Edwards RA, Pannunzio NR, Seldin MM, Waterman ML, et al. Disruption of the circadian clock drives loss of heterozygosity to accelerate colorectal cancer. Science Advances. 8: eabo2389. PMID 35947664 DOI: 10.1126/sciadv.abo2389 |
0.669 |
|
| 2021 |
Chen GT, Tifrea DF, Murad R, Habowski AN, Lyou Y, Duong MR, Hosohama L, Mortazavi A, Edwards RA, Waterman ML. Disruption of beta-catenin dependent Wnt signaling in colon cancer cells remodels the microenvironment to promote tumor invasion. Molecular Cancer Research : McR. PMID 34799404 DOI: 10.1158/1541-7786.MCR-21-0349 |
0.691 |
|
| 2021 |
Martin K, Zhang T, Lin TT, Habowski AN, Zhao R, Tsai CF, Chrisler WB, Sontag RL, Orton DJ, Lu YJ, Rodland KD, Yang B, Liu T, Smith RD, Qian WJ, et al. Facile One-Pot Nanoproteomics for Label-Free Proteome Profiling of 50-1000 Mammalian Cells. Journal of Proteome Research. PMID 34351778 DOI: 10.1021/acs.jproteome.1c00403 |
0.541 |
|
| 2020 |
Habowski AN, Flesher JL, Bates JM, Tsai CF, Martin K, Zhao R, Ganesan AK, Edwards RA, Shi T, Wiley HS, Shi Y, Hertel KJ, Waterman ML. Publisher Correction: Transcriptomic and proteomic signatures of stemness and differentiation in the colon crypt. Communications Biology. 3: 495. PMID 32884070 DOI: 10.1038/s42003-020-01237-0 |
0.576 |
|
| 2020 |
Tran TQ, Hanse EA, Habowski AN, Li H, Gabra MBI, Yang Y, Lowman XH, Ooi AM, Liao SY, Edwards RA, Waterman ML, Kong M. α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer. Nature Cancer. 1: 345-358. PMID 32832918 DOI: 10.1038/S43018-020-0035-5 |
0.712 |
|
| 2020 |
Habowski AN, Flesher JL, Bates JM, Tsai CF, Martin K, Zhao R, Ganesan AK, Edwards RA, Shi T, Wiley HS, Shi Y, Hertel KJ, Waterman ML. Transcriptomic and proteomic signatures of stemness and differentiation in the colon crypt. Communications Biology. 3: 453. PMID 32814826 DOI: 10.1038/s42003-020-01181-z |
0.618 |
|
| 2020 |
Tran TQ, Hanse EA, Habowski AN, Li H, Ishak Gabra MB, Yang Y, Lowman XH, Ooi AM, Liao SY, Edwards RA, Waterman ML, Kong M. α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer Nature Cancer. 1: 345-358. DOI: 10.1038/S43018-020-0035-5 |
0.686 |
|
| 2017 |
Lyou Y, Habowski AN, Chen GT, Waterman ML. Inhibition of Nuclear Wnt Signaling: Challenges of an Elusive Target for Cancer Therapy. British Journal of Pharmacology. PMID 28752891 DOI: 10.1111/Bph.13963 |
0.664 |
|
| 2017 |
Lyou Y, Habowski A, Sprowl-Tanio S, Pate K, Chen G, Waterman ML. Abstract 5494: Hypoxia via HIF1alpha can regulate Wnt signaling in human colon cancer cells Cancer Research. 77: 5494-5494. DOI: 10.1158/1538-7445.Am2017-5494 |
0.672 |
|
| 2016 |
Sprowl-Tanio S, Habowski AN, Pate KT, McQuade MM, Wang K, Edwards RA, Grun F, Lyou Y, Waterman ML. Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer. Cancer & Metabolism. 4: 20. PMID 27729975 DOI: 10.1186/S40170-016-0159-3 |
0.666 |
|
| Show low-probability matches. |